Development of Highly Potent Clinical Candidates for Theranostic Applications against Cholecystokinin-2 Receptor Positive Cancers. - Corlett A; Pinson JA; Rahimi MN; Zuylekom JV; Cullinane C; Blyth B; Thompson PE; Hutton CA; Roselt PD; Haskali MB (Journal of medicinal chemistry, 2023)